Connect to share and comment

FDA is reviewing drugmaker Merck's immune therapy tablet for gradually easing ragweed allergy

PlacardEnlarge
(Globalpost/GlobalPost)

WHITEHOUSE STATION, N.J. - Drugmaker Merck

Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue. Patients in studies of the tablet took it daily for a year.

It could become an alternative to months of uncomfortable allergy shots. Both methods gradually desensitize the immune system to the substance triggering the allergic reaction.

In March, the Whitehouse Station, N.J., company said the FDA was reviewing its application for an immunotherapy tablet for grass pollen allergies.

Merck expects FDA rulings on both still-unnamed treatments in 2014's first half.

http://www.globalpost.com/dispatch/news/the-canadian-press/130508/fda-reviewing-drugmaker-mercks-immune-therapy-tablet-gradual